Journal
Therapeutic Advances in Neurological Disorders
Publication Date
4-1-2024
Volume
17
First Page
17562864241241383
Document Type
Open Access Publication
DOI
10.1177/17562864241241383
Rights and Permissions
Shirani A, Cross AH, Stuve O. Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database. Ther Adv Neurol Disord. 2024 Apr 1;17:17562864241241383. doi: 10.1177/17562864241241383. © The Author(s), 2024. Creative Commons License (CC BY-NC 4.0) This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Recommended Citation
Shirani, Afsaneh; Cross, Anne H; and Stuve, Olaf, "Exploring the association between weight loss-inducing medications and multiple sclerosis: Insights from the FDA adverse event reporting system database." Therapeutic Advances in Neurological Disorders. 17, 17562864241241383 (2024).
https://digitalcommons.wustl.edu/oa_4/3650
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
